132995-76-7 Usage
General Description
2-(2-Hydroxyethyl)morpholine is a chemical compound used for various applications in scientific and industrial domains. The chemical belongs to the family of morpholines, which means it incorporates a heterocyclic organic compound composed of a six-membered ring containing four carbon atoms, one nitrogen atom, and one oxygen atom in its molecular structure. This specific derivation, characterized by the additional hydroxyethyl group, often serves as a reagent in synthetic chemistry, facilitating chemical transformations. It is colorless to pale yellow in appearance and has a distinctive, amine-like odor. Safety measures should be taken when handling 2-(2-Hydroxyethyl)morpholine, as the chemical carries a potential risk of causing eye irritation.
Check Digit Verification of cas no
The CAS Registry Mumber 132995-76-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,2,9,9 and 5 respectively; the second part has 2 digits, 7 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 132995-76:
(8*1)+(7*3)+(6*2)+(5*9)+(4*9)+(3*5)+(2*7)+(1*6)=157
157 % 10 = 7
So 132995-76-7 is a valid CAS Registry Number.
InChI:InChI=1/C6H13NO2/c8-3-1-6-5-7-2-4-9-6/h6-8H,1-5H2
132995-76-7Relevant articles and documents
INDAZOLE BASED COMPOUNDS AND ASSOCIATED METHODS OF USE
-
, (2021/10/02)
Bifunctional compounds, which find utility as modulators of leucine-rich repeat kinase 2 (LRRK2), are described herein. In particular, the hetero-bifunctional compounds of the present disclosure contain on one end a moiety that binds to the cereblon E3 ubiquitin ligase and on the other end a moiety which binds LRRK2, such that the target protein is placed in proximity to the ubiquitin ligase to effect degradation (and inhibition) of target protein. The hetero-bifunctional compounds of the present disclosure exhibit a broad range of pharmacological activities associated with degradation/inhibition of target protein. Diseases or disorders that result from aberrant regulation of the target protein are treated or prevented with compounds and compositions of the present disclosure.
Antipicorpaviral herterocyclic-substituted morpholinyl alkylphenol ethers
-
, (2008/06/13)
Novel (thio)morpholinyl and piperazinyl alkylphenol ethers having antirhinoviral activity, compositions containing these compounds as active ingredient, and a method of inhibiting, combating or preventing the growth of viruses in warm-blooded animals suff
